Viemed Healthcare, Inc.
NASDAQ:VMDMedical - Devices
Healthcare
$8.61 +0.68%
+$0.07 today
- Market cap
- $326.26M
- Beta
- 1.13
- P/E (TTM)
- 27.4
- EPS (TTM)
- $0.39
52W Low $5.93High $10.68
Volume 0.17M
Average 0.26M
Income Statement
Follow revenue through to earnings.
Revenue
$270.28M
FY 2025 · Annual
+20.5% YoYOperating Income
$20.71M
FY 2025 · Annual
+15.7% YoYNet Income
$14.93M
FY 2025 · Annual
+32.6% YoYIncome Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 117.06M | 138.83M | 183.01M | 224.26M | 270.28M |
| Cost of Revenue | 43.65M | 54.15M | 70.23M | 91.05M | 114.82M |
| Gross Profit | 73.41M | 84.68M | 112.78M | 133.2M | 155.46M |
| Gross Margin | 62.7% | 61.0% | 61.6% | 59.4% | 57.5% |
| Research & Development | 2.11M | 2.7M | 2.78M | 3.07M | 3.02M |
| Selling, General & Admin | 60.04M | 73.36M | 93.73M | 112.48M | 130.5M |
| Operating Expenses | 61.83M | 76.43M | 98.45M | 115.3M | 134.75M |
| Depreciation & Amortization | 11.31M | 15.63M | 21.86M | 25.37M | 28.61M |
| EBITDA | 24.13M | 24.82M | 36.68M | 42.31M | 51.56M |
| EBITDA Margin | 20.6% | 17.9% | 20.0% | 18.9% | 19.1% |
| Operating Income | 11.58M | 8.25M | 14.33M | 17.9M | 20.71M |
| Operating Margin | 9.9% | 5.9% | 7.8% | 8.0% | 7.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 318K | 197K | 424K | 776K | 1.18M |
| Other Income / Expenses | 923K | 738K | 61K | (1.73M) | 1.06M |
| Income Before Tax | 12.5M | 8.99M | 14.39M | 16.17M | 21.77M |
| Pre-Tax Margin | 10.7% | 6.5% | 7.9% | 7.2% | 8.1% |
| Income Tax Expense | 3.38M | 2.77M | 4.15M | 4.76M | 6.39M |
| Net Income | 9.13M | 6.22M | 10.24M | 11.27M | 14.93M |
| Net Margin | 7.8% | 4.5% | 5.6% | 5.0% | 5.5% |
| EPS (Basic) | 0.23 | 0.15 | 0.27 | 0.29 | 0.38 |
| EPS (Diluted) | 0.22 | 0.15 | 0.25 | 0.28 | 0.37 |
| 39.49M | 38.66M | 38.35M | 38.76M | 38.9M | |
| 40.68M | 39.81M | 40.38M | 40.81M | 40.82M |
VMD Earnings Waterfall · TTM
NASDAQ:VMD · Revenue to Net Income
Key Ratios
EPS$0.37
Gross Margin57.3%
Net Margin5.2%
P/E Ratio21.8
P/S Ratio4.1
Analysis
$286.6M of revenue converted into $14.9M of net income for the selected period. Gross margin is 57.3% and net margin is 5.2%, showing how much revenue survives after costs and taxes. EPS is $0.37, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 4, 2026 | |
| 10-Q | Quarterly report | Nov 4, 2026 | |
| SC 13D/A | SC 13D/A filing | Sep 24, 2026 | |
| 8-K | Current report | Aug 20, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 19, 2026 |
How much revenue does VMD generate?
Viemed Healthcare, Inc. (VMD) reported $270.28M of revenue in fiscal 2025.
Is VMD profitable?
Viemed Healthcare, Inc. (VMD) reported $14.93M of net income, with a net margin of 5.5%.
Continue the stock analysis
Jump to another research area for this company.